Getinge AB
STO:GETI B
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
175.7
239.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GETI B stock under the Base Case scenario is 268.73 SEK. Compared to the current market price of 226.6 SEK, Getinge AB is Undervalued by 16%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Getinge AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GETI B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Getinge AB
Balance Sheet Decomposition
Getinge AB
Current Assets | 16.5B |
Cash & Short-Term Investments | 2.3B |
Receivables | 7B |
Other Current Assets | 7.2B |
Non-Current Assets | 38.8B |
Long-Term Investments | 66m |
PP&E | 5.6B |
Intangibles | 32.2B |
Other Non-Current Assets | 941m |
Current Liabilities | 14.3B |
Accounts Payable | 2.3B |
Other Current Liabilities | 12.1B |
Non-Current Liabilities | 9.4B |
Long-Term Debt | 4.2B |
Other Non-Current Liabilities | 5.2B |
Earnings Waterfall
Getinge AB
Revenue
|
33.3B
SEK
|
Cost of Revenue
|
-17.9B
SEK
|
Gross Profit
|
15.4B
SEK
|
Operating Expenses
|
-11.1B
SEK
|
Operating Income
|
4.3B
SEK
|
Other Expenses
|
-1.7B
SEK
|
Net Income
|
2.6B
SEK
|
Free Cash Flow Analysis
Getinge AB
SEK | |
Free Cash Flow | SEK |
In Q2 2024, Getinge saw net sales rise by 15.7% and organic growth of 8.9%. The order intake grew by 14.4%, with 7.8% organic growth. Adjusted gross margins improved across all business areas, and the adjusted EBITDA margin increased by 4.9 percentage points. New product launches, like the Poladus 150 sterilizer and the GEW 888 neo washer, were highlighted as key drivers. The company reiterated its full-year guidance of 2%-5% organic net sales growth, with recent acquisitions expected to add 3-5 percentage points. This robust performance ensures a solid financial position for future profitable growth.
What is Earnings Call?
GETI B Profitability Score
Profitability Due Diligence
Getinge AB's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Getinge AB's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
GETI B Solvency Score
Solvency Due Diligence
Getinge AB's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Getinge AB's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GETI B Price Targets Summary
Getinge AB
According to Wall Street analysts, the average 1-year price target for GETI B is 241.75 SEK .
Shareholder Yield
Current shareholder yield for GETI B is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
GETI B Price
Getinge AB
Average Annual Return | 24.27% |
Standard Deviation of Annual Returns | 60.52% |
Max Drawdown | -57% |
Market Capitalization | 61.7B SEK |
Shares Outstanding | 272 369 600 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 10,729 full-time employees. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Contact
IPO
Employees
Officers
The intrinsic value of one GETI B stock under the Base Case scenario is 268.73 SEK.
Compared to the current market price of 226.6 SEK, Getinge AB is Undervalued by 16%.